Pieris Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,761.90
18,474.20
29,349.10
29,355.50
72,629.00
128,107
Total Accounts Receivable
809.90
-
-
57.60
15,546.00
2,701
Other Current Assets
248.60
1,331.20
2,311.40
3,259.50
1,615.00
4,574
Total Current Assets
4,820.40
19,805.40
31,660.50
32,672.60
89,790.00
135,382
Net Property, Plant & Equipment
2,437.70
2,052.20
2,162.80
2,264.50
4,034.00
5,049
Total Investments and Advances
-
-
-
-
9,922.00
-
Long-Term Note Receivable
121.80
-
-
-
-
-
Other Assets
-
-
126.80
125.70
130.00
910
Total Assets
7,398.70
21,857.60
33,950.10
35,062.80
103,876.00
141,341
ST Debt & Current Portion LT Debt
227.10
1,270.60
-
-
-
Accounts Payable
278.00
1,260.00
1,058.50
2,386.20
2,452.00
Income Tax Payable
18.90
-
-
-
-
Other Current Liabilities
1,244.00
986.60
1,739.40
5,994.00
43,323.00
Total Current Liabilities
1,768.10
3,517.20
2,797.90
8,380.20
45,775.00
Long-Term Debt
3,924.50
-
-
-
-
Provision for Risks & Charges
373.10
327.90
-
-
-
Deferred Taxes
18.90
-
-
-
-
Other Liabilities
626.40
6.10
23.90
1,456.20
46,579.00
Total Liabilities
6,691.90
3,851.20
2,821.80
9,836.30
92,354.00
Common Equity (Total)
706.80
18,006.40
31,128.30
25,226.50
11,522.00
Total Shareholders' Equity
706.80
18,006.40
31,128.30
25,226.50
11,522.00
Total Equity
706.80
18,006.40
31,128.30
25,226.50
11,522.00
Liabilities & Shareholders' Equity
7,398.70
21,857.60
33,950.10
35,062.80
103,876.00
Preferred Stock (Carrying Value)
-
-
-
0.00
-
About Pieris Pharmaceuticals
View Profile
